Literature DB >> 11092971

Mutations and reduced expression of the transforming growth factor-beta receptor II gene in rat lung adenocarcinomas induced by N-nitrosobis-(2-hydroxypropyl)amine.

T Tsujiuchi1, Y Sasaki, M Tsutsumi, Y Konishi.   

Abstract

Mutations and expression of the transforming growth factor-beta receptor type II (TGF-beta RII) gene were investigated in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine (BHP) in rats. Males of the Wistar strain, 6 weeks old, were given 2000 ppm of BHP in their drinking water for 12 weeks and then maintained without further treatment until killed at week 25. Total RNA was extracted from 12 adenocarcinomas and mutations in TGF-beta RII were investigated by RT-PCR-restriction-SSCP analysis followed by sequencing analysis. Two out of 12 adenocarcinomas showed band shifts, indicative of mutations (16.7%). One was a CTG-to-TTG (Leu to Leu) transition at codon 308 without amino acid alteration and the other a frameshift deletion of one of two guanines at nucleotides 1434 to 1435 (codon 477 to 478). Semi-quantitative RT-PCR analysis demonstrated significantly reduced TGF-beta RII expression in adenocarcinomas, as compared with normal lung tissue. These results suggest that TGF-beta RII alterations may play a role in the acquisition of growth advantage by lung adenocarcinomas induced by BHP in rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092971      PMCID: PMC5926282          DOI: 10.1111/j.1349-7006.2000.tb00889.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  29 in total

1.  Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.

Authors:  H Y Lin; X F Wang; E Ng-Eaton; R A Weinberg; H F Lodish
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

2.  Frequent aberrant methylation of p16INK4a in primary rat lung tumors.

Authors:  D S Swafford; S K Middleton; W A Palmisano; K J Nikula; J Tesfaigzi; S B Baylin; J G Herman; S A Belinsky
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 3.  Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

Authors:  A B Roberts; M B Sporn
Journal:  Growth Factors       Date:  1993       Impact factor: 2.511

4.  Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type II messenger RNA and protein.

Authors:  D Lazzereschi; A Ranieri; G Mincione; S Taccogna; F Nardi; G Colletta
Journal:  Cancer Res       Date:  1997-05-15       Impact factor: 12.701

5.  Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta.

Authors:  K Park; S J Kim; Y J Bang; J G Park; N K Kim; A B Roberts; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

6.  The TGF-beta family and its composite receptors.

Authors:  J Massagué; L Attisano; J L Wrana
Journal:  Trends Cell Biol       Date:  1994-05       Impact factor: 20.808

7.  A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability.

Authors:  L L Myeroff; R Parsons; S J Kim; L Hedrick; K R Cho; K Orth; M Mathis; K W Kinzler; J Lutterbaugh; K Park
Journal:  Cancer Res       Date:  1995-12-01       Impact factor: 12.701

8.  Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells.

Authors:  J Wang; L Sun; L Myeroff; X Wang; L E Gentry; J Yang; J Liang; E Zborowska; S Markowitz; J K Willson
Journal:  J Biol Chem       Date:  1995-09-15       Impact factor: 5.157

9.  Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats.

Authors:  H Kitada; M Tsutsumi; T Tsujiuchi; M Takahama; T Fukuda; N Narita; Y Konsihi
Journal:  Mol Carcinog       Date:  1996-04       Impact factor: 4.784

10.  GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.

Authors:  R Wieser; J L Wrana; J Massagué
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

View more
  1 in total

1.  No Mutations of Lysophosphatidic Acid Receptor Genes in Lung Adenocarcinomas Induced by N-Nitrosobis(2-hydroxypropyl)amine in Rats.

Authors:  Naoko Wakabayashi; Megumu Tsujino; Masaki Tajiri; Midori Taki; Ayumi Koshino; Hiroko Ikeda; Nobuyuki Fukushima; Toshifumi Tsujiuchi
Journal:  J Toxicol Pathol       Date:  2010-04-05       Impact factor: 1.628

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.